Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and ...

Scientists from the Barts Cancer Institute and the Francis Crick Institute have demonstrated that a genetic flaw that has ...

A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer.

Prof. Gaofeng Liang from Clinical Medical College and Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan University of Science and Technology Disclaimer ...

BGB-10188 is under clinical development by BeiGene and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase II drugs for Esophageal Cancer have a 25% phase transition success ...

A surprising discovery reveals that a gene previously thought to accelerate esophageal cancer actually helps protect against it initially. This pivotal study could lead to better prediction and ...

The following is a summary of “Impact of preceding treatment for head and neck squamous cell carcinoma on synchronous ...

That's when doctors discover a tumor that has grown into the walls of the esophagus, and likely beyond. "At that point," Kahn ...

LY-4101174 is under development for the treatment of solid tumors, urothelial carcinoma, triple negative breast cancer, non-small cell lung cancer, esophageal cancer, pancreatic c ...